Yanling Chen
Impact in
- Molecular Biology top 5%
- Genomics and Phylogenetic Studies
- Bacterial biofilms and quorum sensing
- Protein Degradation and Inhibitors
-
- Environmental Toxicology and Ecotoxicology
Papers in
-
- Protein Degradation and Inhibitors 12
- Retinoids in leukemia and cellular processes 5
- Advanced biosensing and bioanalysis techniques 4
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Co-authors
- De‐Sheng Pei (3 shared papers)Wan-Ping Bian (3 shared papers)Na Chen (1 shared paper)Yujie Dai (1 shared paper)Qinkai Li (1 shared paper)Yanbo Ma (1 shared paper)Yongfang Jia (1 shared paper)Feifei She (16 shared papers)
- Journals
- PLoS ONE (4 papers)Frontiers in Molecular Biosciences (3 papers)BMC Cancer (3 papers)Tumor Biology (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yanling Chen
132 papers receiving 4.4k citations
Yanling Chen's Hit Papers
Peers
Comparison fields: 5 of 131
- Molecular Biology 1.9k
- Health, Toxicology and Mutagenesis 288
- Genetics 529
- Oncology 366
- Plant Science 540
Countries citing papers authored by Yanling Chen
This map shows the geographic impact of Yanling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Chen more than expected).
Fields of papers citing papers by Yanling Chen
This network shows the impact of papers produced by Yanling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Chen. The network helps show where Yanling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The sequence and de novo assembly of the giant panda genome Hit paper breakdown → | 2009 | 947 |
| 2 | Zebrafish as a model system to study toxicology Hit paper breakdown → | 2013 | 480 |
| 3 | 2017 | 276 | |
| 4 | 2017 | 239 | |
| 5 | 2011 | 170 | |
| 6 | 2012 | 116 | |
| 7 | 2023 | 110 | |
| 8 | 2009 | 100 | |
| 9 | 2009 | 82 | |
| 10 | 2019 | 72 | |
| 11 | Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma. | 2011 | 69 |
| 12 | 2021 | 63 | |
| 13 | 2017 | 54 | |
| 14 | 2014 | 47 | |
| 15 | 2014 | 47 | |
| 16 | 2016 | 46 | |
| 17 | 2023 | 46 | |
| 18 | 2010 | 43 | |
| 19 | 2021 | 43 | |
| 20 | 2018 | 37 |
About Yanling Chen
Yanling Chen is a scholar working on Molecular Biology, Hepatology, Oncology, Immunology and Surgery, having authored 139 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Protein Degradation and Inhibitors (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Aquaculture disease management and microbiota (6 papers), Retinoids in leukemia and cellular processes (5 papers), Neuroblastoma Research and Treatments (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). The work is most often cited by research in Molecular Biology (1.9k citations), Health, Toxicology and Mutagenesis (288 citations), Genetics (529 citations), Oncology (366 citations) and Plant Science (540 citations). Yanling Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include De‐Sheng Pei, Wan-Ping Bian, Na Chen, Yujie Dai, Qinkai Li, Yanbo Ma, Yongfang Jia, Feifei She, Xiaoqian Wang and Qiang Du. Their work appears in journals such as PLoS ONE, Frontiers in Molecular Biosciences, BMC Cancer, Tumor Biology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.